Glutamine synthetase (GS) is a metabolic enzyme (now known to be upregulated by β-catenin signaling [41], as discussed above) that had also been shown to be overexpressed in primary liver cancer (Figure 4) [42]. This evidence concerns the gene GLUL and liver cancer.